Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-071377
Filing Date
2008-03-31
Accepted
2008-03-31 17:23:57
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1095891
2 CODE OF BUSINESS CONDUCT dex141.htm EX-14.1 101980
3 LIST OF SUBSIDIARIES dex211.htm EX-21.1 7045
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 1684
5 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 8128
6 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 8101
7 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 4238
8 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 4200
9 GRAPHIC g84031g01y93.jpg GRAPHIC 78177
10 GRAPHIC g84031g04g06.jpg GRAPHIC 43031
11 GRAPHIC g84031snap0048.gif GRAPHIC 8214
  Complete submission text file 0001193125-08-071377.txt   1411541
Mailing Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025
Business Address 11755 WILSHIRE BLVD., 20TH FLOOR LOS ANGELES CA 90025 310-883-1300
Abraxis Biosciences, Inc. (Filer) CIK: 0001409012 (see all company filings)

EIN.: 300431735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33657 | Film No.: 08726311
SIC: 2834 Pharmaceutical Preparations